Cincor to be Acquired by AstraZeneca

Posted by ISPE Boston
On January 13, 2023

Waltham-based, clinical-stage biopharm CinCor is slated to be acquired by British pharmaceutical giant AstraZeneca. Founded in 2018, CinCor’s mission is to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, is in clinical development for the treatment of hypertension. Under the terms of the merger agreement, AstraZeneca will acquire all of […]

Biogen, Eisai Alzheimer’s Drug Wins FDA Approval

Posted by ISPE Boston
On January 13, 2023

Eisai and Biogen have announced that the FDA has approved lecanemab-irmb (brand-named Leqembi in the U.S.) for the treatment of Alzheimer’s disease (AD) under the Accelerated Approval Pathway. The approval is based on Phase 2 data that demonstrated that Leqembi reduced the accumulation of amyloid beta (Aβ) plaque in the brain, a defining feature of […]

Chapter Member Anniversaries: January 2023

Posted by ISPE Boston
On January 3, 2023

Please congratulate the following members celebrating milestone anniversaries in January 2023. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Daniel Dumont, Dynamic Systems Inc William Lynch, Dycem James Vogel, The BioProcess Institute Brian Clark, GMP Operations Consulting Andrew Coull, J.M. Coull, Inc. Michael Pacek, Stilmas Americas Michael […]

Welcome New Members December 2022!

Posted by ISPE Boston
On January 3, 2023

We would like to introduce the Members who joined ISPE in December 2022, welcome them to the Chapter and encourage them (and all our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And the […]

Happy Holidays from ISPE Boston!

Posted by ISPE Boston
On December 20, 2022

On behalf of all of us at the ISPE Boston Area Chapter, it is my pleasure to wish everyone and their families a joyful holiday season and peaceful New Year! This year, our committees collaborated and created many fabulous events throughout 2022 and we are so grateful for all of our dedicated volunteers, members, and […]

Retro Ski Social was Totally Rad!

Posted by Sean Keenan
On December 16, 2022

We had a wonderful turnout for the Emerging Leaders 2022 finale event – the Retro Winter Social! Tons of people dressed up to show off their Christmas spirit, their love of skiing, and their dad’s old 80’s ski jackets! We gave out big raffle awards to two lucky winners, and three trophies to best dressed. […]

Moderna’s mRNA Cancer Vaccine Shows Promise

Posted by ISPE Boston
On December 15, 2022

Moderna and Merck have announced that the Phase 2b trial of their investigational personalized mRNA melanoma cancer vaccine (mRNA-4157/V940) in combination with Merck’s Keytruda demonstrated a statistically significant and clinically meaningful improvement in recurrence-free survival versus Keytruda alone. These results are the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized […]

Wave Life Sciences and GSK Announce Collaboration

Posted by ISPE Boston
On December 15, 2022

Clinical-stage genetic medicines company Wave Life Sciences and GSK have announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave’s WVE-006 preclinical RNA editing program targeting alpha-1 antitrypsin deficiency (AATD). The discovery collaboration has an initial four-year research term. It combines GSK’s unique insights from human genetics, as well as its global development and commercial capabilities, […]

Clear Creek Bio to Work with Pfizer on COVID Pill

Posted by ISPE Boston
On December 8, 2022

Cambridge startup Clear Creek Bio has announced that it will collaborate with Pfizer to develop inhibitors of the SARS-CoV-2 papain-like protease (PLpro) for the oral treatment of COVID-19. PLpro is an essential enzyme, which, along with the main protease (Mpro), plays an important role in viral replication. This program will expand Pfizer’s innovative anti-infective pipeline […]

MIT Scientists Design New CRISPR Tool to Edit Genes

Posted by ISPE Boston
On December 8, 2022

Building on the CRISPR gene-editing system, MIT researchers have designed a new tool that can snip out faulty genes and replace them with new ones, in a safer and more efficient way. Using this system, the researchers showed that they could deliver genes as long as 36,000 DNA base pairs to several types of human […]

Page 27 of 118«‹25 262728 29 ›»